126 related articles for article (PubMed ID: 15816717)
1. [Bosentan].
Taéron C
Rev Infirm; 2005 Feb; (108):33-4. PubMed ID: 15816717
[No Abstract] [Full Text] [Related]
2. [Endothelin receptor antagonist bosentan. Breakthrough in the treatment of pulmonary hypertension].
MMW Fortschr Med; 2004 Dec; 146(50):72-3. PubMed ID: 15666438
[No Abstract] [Full Text] [Related]
3. Bosentan therapy for pulmonary arterial hypertension.
Rubin LJ; Badesch DB; Barst RJ; Galie N; Black CM; Keogh A; Pulido T; Frost A; Roux S; Leconte I; Landzberg M; Simonneau G
N Engl J Med; 2002 Mar; 346(12):896-903. PubMed ID: 11907289
[TBL] [Abstract][Full Text] [Related]
4. Bosentan.
Mathier MA; Ishizawar D
Expert Opin Pharmacother; 2010 Apr; 11(6):1023-34. PubMed ID: 20307226
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of persistent pulmonary hypertension of the newborn with bosentan.
Nakwan N; Choksuchat D; Saksawad R; Thammachote P; Nakwan N
Acta Paediatr; 2009 Oct; 98(10):1683-5. PubMed ID: 19523174
[TBL] [Abstract][Full Text] [Related]
6. Bosentan for the treatment of adult pulmonary hypertension.
Dwyer N; Kilpatrick D
Future Cardiol; 2011 Jan; 7(1):19-37. PubMed ID: 21174507
[TBL] [Abstract][Full Text] [Related]
7. [Bosentan in pulmonary hypertension].
Heinzl S
Med Monatsschr Pharm; 2002 Mar; 25(3):74-6. PubMed ID: 11925765
[No Abstract] [Full Text] [Related]
8. Bosentan for chronic thromboembolic pulmonary hypertension.
Confalonieri M; Kodric M; Longo C; Vassallo FG
Expert Rev Cardiovasc Ther; 2009 Dec; 7(12):1503-12. PubMed ID: 19954311
[TBL] [Abstract][Full Text] [Related]
9. [Bosentan for treatment of heart failure].
Yoshimoto T; Hirata Y
Nihon Rinsho; 2007 May; 65 Suppl 5():159-63. PubMed ID: 17571378
[No Abstract] [Full Text] [Related]
10. Bosentan.
Chin K; Channick R
Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):175-82. PubMed ID: 15151466
[TBL] [Abstract][Full Text] [Related]
11. Dual endothelin receptor antagonism in pulmonary arterial hypertension.
Pittrow D; Kirch W
Eur J Clin Invest; 2006 Sep; 36 Suppl 3():v-vi. PubMed ID: 16919003
[No Abstract] [Full Text] [Related]
12. Thrombotic microangiopathic nephropathy, pulmonary hypertension and nephromegaly: case report of a patient treated with endothelin receptor antagonist.
Losito A; Pittavini L; Covarelli C
Clin Nephrol; 2012 Feb; 77(2):164-70. PubMed ID: 22257549
[TBL] [Abstract][Full Text] [Related]
13. [Blockade of endothelin receptor with bosentan--a new principle of treatment in pulmonary arterial hypertension].
Nielsen-Kudsk JE
Ugeskr Laeger; 2003 Jul; 165(29):2891-4. PubMed ID: 12908360
[TBL] [Abstract][Full Text] [Related]
14. [Bosentan: a new pillar in the treatment of pulmonary hypertension?].
Matthes J; Groner F
Dtsch Med Wochenschr; 2006 May; 131(18):1031-4. PubMed ID: 16673229
[No Abstract] [Full Text] [Related]
15. Bosentan for pulmonary arterial hypertension.
Drug Ther Bull; 2003 Sep; 41(9):70-2. PubMed ID: 14531210
[TBL] [Abstract][Full Text] [Related]
16. [PAH and many other indications. Old and new endothelin receptor antagonists.].
Schmitz J; Holzgrabe U
Pharm Unserer Zeit; 2010 Nov; 39(6):430-5. PubMed ID: 20967930
[No Abstract] [Full Text] [Related]
17. Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial.
Jaïs X; D'Armini AM; Jansa P; Torbicki A; Delcroix M; Ghofrani HA; Hoeper MM; Lang IM; Mayer E; Pepke-Zaba J; Perchenet L; Morganti A; Simonneau G; Rubin LJ;
J Am Coll Cardiol; 2008 Dec; 52(25):2127-34. PubMed ID: 19095129
[TBL] [Abstract][Full Text] [Related]
18. Clinical features and endothelin receptor antagonist in primary Sjögren's syndrome with pulmonary arterial hypertension.
Chen CH; Chen HA; Yang KY; Yu WC; Liao HT; Huang DF
Scand J Rheumatol; 2006; 35(3):245-7. PubMed ID: 16766376
[No Abstract] [Full Text] [Related]
19. [Young patient with stress dyspnea of uncertain origin. Evaluate for pulmonary hypertension!].
MMW Fortschr Med; 2002 Oct; 144(42):64. PubMed ID: 12534004
[No Abstract] [Full Text] [Related]
20. Bosentan increases serum IL-12 levels in systemic sclerosis patients with pulmonary arterial hypertension.
Hamaguchi Y; Fujimoto M; Hasegawa M; Matsushita T; Takehara K
J Dermatol Sci; 2009 Jul; 55(1):66-7. PubMed ID: 19342201
[No Abstract] [Full Text] [Related]
[Next] [New Search]
